Therapeutic Group: Anti Diabetic Presentation Losucon M 1/500 SR : Each sustained release tablet contains Glimepiride BP 1 mg and Metformin HCL BP 500 mg Description Losucon M SR is a combination of 2 oral anti-hyperglycemic drugs with complimentary mechanism of action to improve glycemic control in patients with type-2 diabetes mellitus: Glimepiride, a Sulfonylurea […]